Trade Summary

1 week ago, Huang Michael F., serving as SVP of Clinical Development at Soleno Therapeutics Inc (SLNO), sold 6,582 shares at $30.44 per share, for a total transaction value of $200,365.00. Following this transaction, Huang Michael F. now holds 39,823 shares of SLNO.

This sale represents a 14.00% decrease in Huang Michael F.'s stake in the company. This is considered a high-conviction trade given the significant change in ownership.

The trade was executed on Friday, March 27, 2026 and publicly disclosed via SEC Form 4 filing on Tuesday, March 31, 2026, 4 days after the trade was made.

Soleno Therapeutics Inc operates in the HEALTHCARE sector, specifically within the BIOTECHNOLOGY industry. Insider selling activity in this sector can provide valuable signals about industry trends and company-specific developments.